These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 36662542)

  • 1. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.
    Ząbczyk M; Ariëns RAS; Undas A
    Cardiovasc Res; 2023 Mar; 119(1):94-111. PubMed ID: 36662542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot properties.
    Bryk AH; Natorska J; Ząbczyk M; Zettl K; Wiśniewski JR; Undas A
    J Proteomics; 2020 Oct; 229():103946. PubMed ID: 32810596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibrin clot proteomics in healthy subjects: Relation to clot permeability and lysis time.
    Ząbczyk M; Stachowicz A; Natorska J; Olszanecki R; Wiśniewski JR; Undas A
    J Proteomics; 2019 Sep; 208():103487. PubMed ID: 31425886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
    Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
    Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
    Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fibrin clot structure and thromboembolism: clinical implications.
    Ząbczyk M; Undas A
    Pol Arch Intern Med; 2017 Dec; 127(12):873-881. PubMed ID: 29225327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
    Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation.
    Bryk-Wiązania AH; Undas A
    Cardiovasc Diabetol; 2021 Sep; 20(1):191. PubMed ID: 34551784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered fibrin clot properties and fibrinolysis in patients with atrial fibrillation: practical implications.
    Undas A
    Europace; 2020 Feb; 22(2):185-194. PubMed ID: 31625555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study.
    Polak MW; Siudut J; Plens K; Undas A
    J Thromb Thrombolysis; 2019 Nov; 48(4):603-609. PubMed ID: 31432450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
    Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
    Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes.
    Ząbczyk M; Natorska J; Undas A
    J Clin Med; 2021 Jul; 10(13):. PubMed ID: 34279484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin Clot Properties in Cancer: Impact on Cancer-Associated Thrombosis.
    Ząbczyk M; Undas A
    Semin Thromb Hemost; 2024 Apr; 50(3):402-412. PubMed ID: 37353045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clot properties and cardiovascular disease.
    Bridge KI; Philippou H; Ariëns R
    Thromb Haemost; 2014 Nov; 112(5):901-8. PubMed ID: 24899357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prothrombotic state and denser clot formation in patients following acute limb ischemia of unknown cause.
    Karpińska IA; Nowakowski T; Wypasek E; Plens K; Undas A
    Thromb Res; 2020 Mar; 187():32-38. PubMed ID: 31951936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B; Gluszko P; Undas A
    Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin clot properties and their modulation in thrombotic disorders.
    Undas A
    Thromb Haemost; 2014 Jul; 112(1):32-42. PubMed ID: 24671700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
    Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
    Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M; Plens K; Wojtowicz W; Undas A
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):365-373. PubMed ID: 28062504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.